ChromoCure, Inc.
Share · US1711271031 (OTC)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ChromoCure, Inc.
No Price
Company Profile for ChromoCure, Inc. Share
ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. The company was formerly known as Cyberhand Technologies International, Inc. and changed its name to ChromoCure, Inc. in June 2009. ChromoCure, Inc. was incorporated in 2001 and is based in Reno, Nevada.
Company Data
Name ChromoCure, Inc.
Company ChromoCure, Inc.
Primary Exchange 
UTC
UTC
ISIN US1711271031
Asset Class Share
Sector Healthcare
Industry Medical - Specialties
Country United States of America
Currency USD
Employees 0,0 T
Address , Reno
IPO Date 2005-04-27
Stock Splits
| Date | Split |
|---|---|
| 05.04.2007 | 3333:1000000 |
| 13.05.2005 | 10000000:3333 |
| 04.04.2005 | 1:200 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | KKUR |
More Shares
Investors who hold ChromoCure, Inc. also have the following shares in their portfolio:
